Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Imunon, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 22 | 19 | −3 |
| Shares | 425.1K | 342.8K | −82.3K (−19.4%) |
| Value | $403.5K | $359.9K | −$43.6K (−10.8%) |
New holders (2)
Institutions that held Imunon, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Van Hulzen Asset Management, LLC | 10,266 | $10.8K | 0.00% |
| FMR LLC | 876 | $920 | 0.00% |
Sold out (5)
Institutions that held Imunon, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| HRT Financial LP | 19,214 | $18.0K |
| Citadel Advisors LLC | 12,825 | $12.2K |
| Citigroup Inc | 1,299 | $1.23K |
| Fourth Dimension Wealth, LLC | 250 | $238 |
| JPMorgan Chase & Co | 100 | $95 |